TRVI

Trevi Therapeutics is a drug development company working on a treatment for chronic cough, a persistent cough that doesn't go away. The company is testing an experimental medicine called Haduvio, which is a form of an existing painkiller called nalbuphine given as a pill. The medicine is currently in clinical trials, which are the testing stages required before the U.S. Food and Drug Administration can approve a new drug for patients to use. Trevi is focusing on people with chronic cough caused by lung diseases, including idiopathic pulmonary fibrosis (a condition where lung tissue becomes sca…